Why the study?
Telerehabilitation could benefit a large population by increasing adherence, prompting a review of cost-utility approaches in its economic evaluations.
Does exercise-based telerehabilitation improve quality of life and cost-effectiveness compared to face-to-face rehabilitation in patients requiring rehabilitation therapy?
Does exercise-based telerehabilitation improve quality of life and cost-effectiveness compared to face-to-face rehabilitation in patients requiring rehabilitation therapy?
Telerehabilitation appears to be a cost-effective and potentially dominant alternative to face-to-face rehabilitation across various disease areas, including cardiovascular diseases.
Telerehabilitation may expand access at lower cost; supports wider economic evaluation in cardiac and other rehab settings.
BACKGROUND Telerehabilitation could benefit a large population by increasing adherence to rehabilitation protocols. OBJECTIVE Our objective was to review and discuss the use of cost-utility approaches in economic evaluations of telerehabilitation interventions. METHODS A review of the literature on PubMed, Scopus, Centres for Review and Dissemination databases (including the HTA database, the Database of Abstracts of Reviews of Effects, and the NHS Economic Evaluation Database), Cochrane Library, and ClinicalTrials.gov (last search on February 8, 2021) was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The inclusion criteria were defined in accordance with the PICOS (population, intervention, comparison, outcomes, and study design) system: the included studies had to evaluate patients in rehabilitation therapy for all diseases and disorders (population) through exercise-based telerehabilitation (intervention) and had to have a control group that received face-to-face rehabilitation (comparison), and these studies had to evaluate effectiveness through gain in quality of life (outcome) and used the design of randomized and controlled clinical studies (study). RESULTS We included 11 economic evaluations, of which 6 concerned cardiovascular diseases. Several types of interventions were assessed as telerehabilitation, consisting in monitoring of rehabilitation at home (monitored by physicians) or a rehabilitation program with exercise and an educational intervention at home alone. All studies were based on randomized clinical trials and used a validated health-related quality of life instrument to describe patients’ health states. Four evaluations used the EQ-5D, 1 used the EQ-5D-5L, 2 used the EQ-5D-3L, 3 used the Short-Form Six-Dimension questionnaire, and 1 used the 36-item Short Form survey. The mean quality-adjusted life years gained using telerehabilitation services varied from –0.09 to 0.89. These results were reported in terms of the probability that the intervention was cost-effective at different thresholds for willingness-to-pay values. Most studies showed results about telerehabilitation as dominant (ie, more effective and less costly) together with superiority or noninferiority in outcomes. CONCLUSIONS There is evidence to support telerehabilitation as a cost-effective intervention for a large population among different disease areas. There is a need for conducting cost-effectiveness studies in countries because the available evidence has limited generalizability in such countries. CLINICALTRIAL PROSPERO CRD42021248785; https://tinyurl.com/4xurdvwf
No takes yet. Share an insight, caveat, or question.
Baffert et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: